Unitensen

   
Google
 
Web NewDrugInformation.com

Unitensen


Drug - Unitensen
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cryptenamine Tannates
Multiple ingredients are in alphabetical order.

Strength - 260CSR UNIT
The potency of the active ingredient(s), Cryptenamine Tannates. May repeat for multiple part products.

Applicant - MEDPOINTE PHARM HLC
The firm name holding legal responsibility for Unitensen. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 009217
The FDA assigned number to Unitensen. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Unitensen. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Unitensen was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Unitensen. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Unitensen is in. Format is RX, OTC, DISCN.

Applicant Full Name - Medpointe Pharmaceuticals Medpointe Healthcare Inc
The full name of the firm holding legal responsibility for the new application of Unitensen.

Unitensen